Brandywine Global Investment Management’s Lifecore Biomedical LFCR Stock Holding History

Brandywine Global Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,507	Closed	-$109K	–	799
2020 Q1	$109K	Buy	12,507 +650	+5%	+$6.76K	﹤0.01%	636
2019 Q4	$133K	Sell	11,857 -138	-1%	-$1.47K	﹤0.01%	673
2019 Q3	$131K	Hold	11,995	–	–	﹤0.01%	663
2019 Q2	$113K	Sell	11,995 -1,985	-14%	-$20K	﹤0.01%	676
2019 Q1	$172K	Hold	13,980	–	–	﹤0.01%	645
2018 Q4	$166K	Hold	13,980	–	–	﹤0.01%	640
2018 Q3	$202K	Buy	+13,980	New	+$193K	﹤0.01%	666
2016 Q1	–	Sell	-11,400	Closed	-$135K	–	999
2015 Q4	$135K	Sell	11,400 -20,900	-65%	-$257K	﹤0.01%	735
2015 Q3	$377K	Hold	32,300	–	–	﹤0.01%	631
2015 Q2	$467K	Sell	32,300 -9,370	-22%	-$135K	﹤0.01%	627
2015 Q1	$582K	Hold	41,670	–	–	﹤0.01%	618
2014 Q4	$576K	Hold	41,670	–	–	﹤0.01%	630
2014 Q3	$511K	Sell	41,670 -780	-2%	-$9.74K	﹤0.01%	615
2014 Q2	$531K	Buy	42,450 +19,560	+85%	+$230K	﹤0.01%	621
2014 Q1	$256K	Hold	22,890	–	–	﹤0.01%	697
2013 Q4	$278K	Hold	22,890	–	–	﹤0.01%	697
2013 Q3	$280K	Buy	+22,890	New	+$319K	﹤0.01%	728

Other funds holding LFCR

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brandywine Global Investment Management's LFCR Position: Q2 2020 in Review

Brandywine Global Investment Management sold out of Lifecore Biomedical (LFCR) in Q2 2020, closing a stake of 12,507 shares — an estimated $109K sold.

Brandywine Global Investment Management first reported a position in LFCR in Q3 2013 and held it in 17 quarters. The position peaked at $582K in Q1 2015. 95 funds tracked by Wall St. Rank hold LFCR as of Q2 2020.

Brandywine Global Investment Management reported no remaining Lifecore Biomedical position as of Q2 2020 after selling out during the quarter.
Brandywine Global Investment Management sold 12,507 Lifecore Biomedical shares in Q2 2020, an estimated $109K.
Brandywine Global Investment Management first reported a position in Lifecore Biomedical in Q3 2013 and held it in 17 quarters.
Brandywine Global Investment Management's Lifecore Biomedical position peaked at $582K in Q1 2015.
95 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2020.

Based on Brandywine Global Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.